Ubs Asset Management Americas Inc Longboard Pharmaceuticals, Inc. Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Longboard Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 55,079 shares of LBPH stock, worth $3.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,079
Previous 50,056
10.03%
Holding current value
$3.3 Million
Previous $1.35 Million
35.62%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LBPH
# of Institutions
126Shares Held
34.9MCall Options Held
28.9KPut Options Held
13.9K-
Farallon Capital Management LLC San Francisco, CA3.15MShares$189 Million0.53% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.91MShares$174 Million0.01% of portfolio
-
Cormorant Asset Management, LP Boston, MA2.79MShares$167 Million6.52% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$142 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.03MShares$122 Million0.0% of portfolio
About Longboard Pharmaceuticals, Inc.
- Ticker LBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,586,000
- Market Cap $815M
- Description
- Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...